ClinicalTrials.gg
Not yet recruitingNCT07679373Updated Jul 1, 2026

Effects of Clinical Based Versus Synchronized Telerehabilitation on Pain, Exercise Adherence, and Functional Disability Among Patients With Grade-II Cervical Spondylosis.

An interventional study of Group A: Clinical Based Rehabilitation and Group B: Synchronized Telerehabilitation in Grade-II Cervical Spondylosis, sponsored by Lahore University of Biological and Applied Sciences. Not yet recruiting at 1 site in Pakistan. Open to participants aged 45 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-07-01.

Sponsored by Lahore University of Biological and Applied Sciences · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
45 Years to 64 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Pain by Lahore University of Biological and Applied Sciences — 6 open to participants now, 7 under way, none of them phase 3. Pain · Lahore University of Biological and Applied Sciences.

Planned enrollment
5th of 11
52 · median 52
Started
2026
with 6 others
No phase
11 of 11
6 open now
Registered
9th of 11
by date

Among the 11 studies in Pain by Lahore University of Biological and Applied Sciences, this one is the 5th largest by planned enrollment, is one of 7 that started in 2026, is one of 11 with no phase, and was the 9th registered.

Pain

10,075 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

6 of the 11 studies in Pain by Lahore University of Biological and Applied Sciences are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 45 Years to 64 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Pain by Lahore University of Biological and Applied Sciences, or all of them as a file.
02

Study summary

This randomized controlled trial aims to compare the effects of clinical-based rehabilitation and synchronized telerehabilitation on pain, exercise adherence, and functional disability in patients with Grade-II cervical spondylosis. A total of 52 participants will be randomly allocated into two parallel groups. Both groups will receive a standardized 6-week rehabilitation program, including cervical mobility exercises, strengthening, isometric exercises, stretching, and Mulligan self-mobilization techniques. The clinical group will receive in-person physiotherapy, while the telerehabilitation group will undergo real-time supervised sessions via video conferencing. Outcome measures will include pain (Numeric Pain Rating Scale), functional disability (Neck Disability Index), and exercise adherence (Exercise Adherence Rating Scale), assessed at baseline and post-intervention. The study aims to determine whether synchronized telerehabilitation is as effective as clinical-based rehabilitation and may provide a more accessible alternative for delivering physiotherapy care.

Read the detailed description

Cervical spondylosis is a common degenerative condition of the cervical spine characterized by disc degeneration, osteophyte formation, and reduced cervical mobility, leading to neck pain and functional limitations. Grade-II cervical spondylosis represents a stage where patients are symptomatic but remain suitable for conservative management. Physiotherapy, particularly exercise-based rehabilitation, is widely used to improve pain, mobility, and functional capacity through strengthening, stretching, and neuromuscular re-education.

Clinical-based rehabilitation provides in-person physiotherapy with direct supervision, manual guidance, and real-time correction of exercises. However, access to such care is often limited due to barriers such as travel distance, cost, and time constraints. Synchronized telerehabilitation, delivered through real-time video conferencing, offers a potential alternative by enabling remote supervision, feedback, and patient engagement while maintaining continuity of care.

This randomized controlled trial aims to compare the effectiveness of clinical-based rehabilitation and synchronized telerehabilitation in patients with Grade-II cervical spondylosis. A total of 52 participants will be randomly assigned to two parallel groups. Both groups will receive a standardized 6-week rehabilitation program consisting of cervical range-of-motion exercises, deep cervical muscle strengthening, isometric exercises, stretching of the upper trapezius and levator scapulae, and Mulligan self-mobilization techniques (SNAGs). The clinical group will attend in-person sessions, while the telerehabilitation group will receive real-time supervised sessions via video conferencing.

Outcome measures include pain intensity assessed by the Numeric Pain Rating Scale (NPRS), functional disability measured by the Neck Disability Index (NDI), and exercise adherence evaluated using the Exercise Adherence Rating Scale (EARS), assessed at baseline and post-intervention.This study aims to determine whether synchronized telerehabilitation is comparable to clinical-based rehabilitation and may provide an accessible, cost-effective alternative for delivering physiotherapy care

03

Conditions studied

  • Grade-II Cervical Spondylosis

Keywords

  • Telerehabilitation
  • Pain
  • Excercise Adherence
  • Functional Disability
  • Cervical Spondylosis
04

Who can participate

Ages eligible
45 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Middle age adults (45-64) years
  • Both gender ( male and female )
  • Clinical daignosis of cervical spondylosis grade 2
  • Mild to moderate pain on NPRS
  • Sub acute stage ( 2-6 weeks) of grade 2 cervical spondylosis
  • Able to follow instructions and give (cognitively able) Neurologically stable

Exclusion criteria

Exclusion Criteria:

  • Prior cervical spine surgery within the last 1 months or cervical instability.
  • Inflammtory or systemic rheumatologic disease affecting the cervical spine (e.g., active rheumatoid arthritis ) or infection, tumor, fracture.
  • Severe cardiopulmonary or other medical comorbidity that contraindicates exercise (unstable angina, uncontriolled hypertension, recent MI)
  • Severe hearing or visual impairment
  • No smoking and daibetic history
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    Group A: Clinical Based Rehabilitation

    Participants in Group A will receive clinical-based rehabilitation through in-person physiotherapy sessions in an outpatient setting. Treatment will be delivered three times per week for 6 weeks, with each session lasting approximately 30-40 minutes. All interventions will be provided under the direct supervision of a qualified physiotherapist, ensuring proper monitoring, guidance, and correction of patient performance during therapy sessions. Participants will also receive standardized instructions for home-based continuation of care on non-supervised days to support consistency of rehabilitation. The focus of this arm is to evaluate the effectiveness of traditional face-to-face physiotherapy care in improving pain, functional disability, and exercise-related outcomes in patients with Grade-II cervical spondylosis.

    Other: Group A: Clinical Based Rehabilitation

  • Active comparator
    Group B: Synchronized Telerehabilitation

    Participants in Group B will receive synchronized telerehabilitation delivered through real-time video conferencing. Sessions will be conducted three times per week for 6 weeks, with each session lasting approximately 30-40 minutes. Rehabilitation will be supervised live by a qualified physiotherapist who will provide instruction, monitoring, and feedback during each session to ensure correct performance and safety. This remote delivery model will replicate the structure of clinical-based rehabilitation while eliminating the need for in-person visits. Participants will also be given standardized guidance for continuing home-based activities on non-session days. This arm aims to evaluate the effectiveness of synchronized telehealth-based physiotherapy in improving pain, functional disability, and exercise adherence in patients with Grade-II cervical spondylosis.

    Other: Group B: Synchronized Telerehabilitation

Interventions

  • OtherGroup A: Clinical Based Rehabilitation

    The first intervention is clinical-based rehabilitation, delivered through in-person physiotherapy sessions in an outpatient clinical setting. Participants will receive supervised treatment three times per week for 6 weeks, with each session lasting approximately 30-40 minutes. All sessions will be conducted by a qualified physiotherapist who will provide direct monitoring, guidance, and correction to ensure proper execution of therapy. This conventional rehabilitation approach emphasizes face-to-face interaction, allowing individualized attention and real-time clinical decision-making. Participants will also be advised to continue prescribed home-based activities on non-session days to maintain consistency and support recovery outcomes.

  • OtherGroup B: Synchronized Telerehabilitation

    The second intervention is synchronized telerehabilitation, delivered through real-time video conferencing sessions. Participants will receive supervised physiotherapy remotely three times per week for 6 weeks, with each session lasting approximately 30-40 minutes. A qualified physiotherapist will provide live instruction, monitoring, and feedback to ensure correct performance and safety during exercises. This approach replicates the structure of clinical-based rehabilitation while eliminating the need for in-person visits. Participants will also be given standardized home-based activity instructions for non-session days to maintain continuity of care. The intervention aims to evaluate the effectiveness of remote, technology-based rehabilitation in improving clinical outcomes in patients with Grade-II cervical spondylosis.

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will rate their average neck pain over the past 24 hours. The NPRS is a valid and reliable tool widely used in musculoskeletal conditions, including cervical spondylosis, to measure changes in pain severity.

    Time frame: Measured at baseline (pre-intervention) and after 6 weeks (post-intervention completion).

  2. Functional Disability

    Functional disability will be assessed using the Neck Disability Index (NDI), a validated questionnaire designed to measure the impact of neck pain on daily activities. It includes domains such as pain intensity, personal care, lifting, reading, work, concentration, sleep, and recreation. Each item is scored, with higher total scores indicating greater disability. The NDI is widely used in cervical spine disorders due to its strong reliability, validity, and sensitivity to clinical change.

    Time frame: Measured at baseline (pre-intervention) and at 6 weeks post-intervention completion.

  3. Exercise Adherence

    Exercise adherence will be assessed using the Exercise Adherence Rating Scale (EARS), a validated self-reported questionnaire designed to measure the extent to which patients comply with prescribed home exercise programs. It evaluates behaviors such as frequency of exercise performance, consistency in following instructions, and patient commitment to rehabilitation. The scale provides insight into adherence patterns that directly influence treatment effectiveness in musculoskeletal conditions. Higher scores indicate better adherence to the prescribed exercise regimen. The EARS is widely used in rehabilitation research due to its good reliability and internal consistency.

    Time frame: Measured at baseline and at 6 weeks post-intervention completion.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — baseline participants

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Oct 2026, 3 months later.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 3 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 25, 2026
First posted
Jul 1, 2026
StartEst.
Jul 1, 2026
Primary completionEst.
Oct 2026
CompletionEst.
Nov 30, 2026
Last update
Jul 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07679373
Lead sponsor
Lahore University of Biological and Applied Sciences
Responsible party
Dr. Khizra Hamid (Senior Lecturer, Lahore University of Biological and Applied Sciences) — Principal investigator
First posted
Jul 1, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Jul 1, 2026

Study contacts

Shoaib Waqas
Contact
shoaibwaqas@gmail.com
+923024552109

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion